Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Sichuan Kelun Pharmaceutical
Company

Sichuan Kelun Pharmaceutical

Tracked across 1 events · 6 articles · First seen Jun 03, 2026 · Last active Jun 03, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 60
Tech
Sichuan Kelun-Biotech SKB500 Study Results
Sichuan Kelun-Biotech Biopharmaceutical announced the positive first-in-human study results for its novel B7-H3 ADC SKB500 at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago, United States. Professor Liu Haifeng from Jilin Provincial…
Impact: Sichuan Kelun-Biotech Biopharmaceutical is a holding subsidiary of Sichuan Kelun Pharmaceutical, meaning the positive study results for SKB500 will also positively impact Sichuan Kelun Pharmaceutical's market standing.
Jun 03, 2026 · 6 articles
NEWSDESK
Track Sichuan Kelun Pharmaceutical live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.